Gala vs IVIM Health: Telehealth GLP-1 Care Comparison
Comparing Gala vs IVIM Health shows two telehealth GLP-1 options with different pricing models, clinical claims, and satisfaction signals. Early verdict: Gala emphasizes a single flat all-inclusive price and free two-day shipping plus a $220 promotion, while IVIM Health emphasizes low entry cost, a free-month code, and dual 4.9-star third-party ratings.
See Gala pricing and $220 promotion
How these providers differ at a glance
This comparison focuses on five distinctive differences supported by the source: pricing structure and entry cost, membership and program fees, third-party ratings and published outcome claims, shipping and fulfillment, and regulatory notes about compounded medications. The name Gala vs IVIM Health is used throughout to keep the focus on direct differences.
Pricing structure and entry cost
Gala presents a flat all-inclusive price covering provider visit, medication, shipping and ongoing care and advertises a $220 promotion. The detailed page evidence notes a $220 discount and that a base price was not exposed in readable page text. The captured data lists a starting price of 179.
Check Gala all-inclusive pricing
IVIM Health lists an explicitly low entry figure and membership incentives. Source evidence shows IVIM starts at $75/mo for semaglutide and $133/mo for tirzepatide, plus a $74.99/mo program fee, and a published first-month pricing pattern including a $99 first month and $174/month ongoing in FAQs. IVIM also advertises a Free Month Membership with code GIFT75 and a no-obligation free consultation valued at $75.
Claim IVIM’s free month with code
Membership, fees and cancellation
Gala states No Monthly Membership and Cancel Anytime and repeatedly emphasizes one flat price at every dose and no hidden fees, with free 2-day shipping. IVIM’s model includes a program fee of $74.99/mo in captured evidence and ongoing pricing that rises after introductory pricing, though IVIM offers a free-month code and a free no-obligation consultation to lower initial cost.
Third-party ratings and outcome claims
IVIM Health is supported by strong third-party review claims in the source: a 4.9-star rating on both Google and Trustpilot. IVIM also highlights internal or proprietary protocol claims, including a statement that patients following its protocol lost an average of 46% more weight over 68 weeks compared to another published clinical trial and a claim that GLP-1 ID can accelerate weight loss by up to 40 percent. The source preserves that these are not head-to-head trials and the 40 percent figure is IVIM’s own protocol claim.
Gala’s source includes patient testimonial-style statements on weight change such as 28 pounds in three months, but the captured evidence also notes that testimonials are provider marketing. Gala emphasizes same price every dose claimed and provider check-ins and dose monitoring included.
Shipping and fulfillment
Gala explicitly advertises Free 2-day shipping straight to your door in the captured landing-page evidence. IVIM’s captured evidence does not emphasize shipping speed; it focuses on program structure, pricing, and satisfaction ratings.
Regulatory and product format
Both providers’ captured evidence states that they offer compounded medications and that compounded medications are not FDA-approved and have not been reviewed by FDA for safety, effectiveness or quality. Gala’s source includes the regulatory note that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. IVIM’s source includes similar captured regulatory language and notes medications are prepared by independent, licensed compounding pharmacies and are prescribed only after consultation with an Ivím provider.
| Criteria | Gala | IVIM Health |
|---|---|---|
| Starting price | $179 listed in captured data; page also advertises compounded semaglutide from $249/mo text noted on page title | $75/mo for semaglutide; $133/mo for tirzepatide in captured evidence |
| Promotions | $220 off promotion advertised | Free Month Membership with code GIFT75 and a no-obligation free consult valued at $75 |
| Membership and fees | No Monthly Membership claimed; one flat price at every dose; Cancel Anytime | |
| Third-party ratings | No third-party rating highlighted in captured evidence | 4.9 stars on Google and Trustpilot in captured evidence |
| Shipping | Free 2-day shipping advertised | Shipping details not emphasized in captured evidence |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA | Compounded drugs are not FDA-approved and have not undergone FDA review |
What the evidence implies for different priorities
If your priority is transparent flat pricing and fast shipping with an advertised promotion, Gala’s captured evidence centers on a single flat all-inclusive price, free two-day shipping, provider check-ins, and a $220 discount. If your priority is low initial cost, strong third-party ratings and a structured clinician protocol with outcome claims, IVIM Health’s captured evidence highlights $75 starting pricing, a free-month code, a no-obligation free consult, 4.9-star ratings, and proprietary protocol outcome claims with explicit qualifiers.
Explore Gala eligibility and terms
Start IVIM’s free consultation
Conclusion: Gala vs IVIM Health
Gala vs IVIM Health comes down to a choice between a flat-price, no-membership pitch with free 2-day shipping and an advertised $220 promotion at Gala, and IVIM Health’s lower advertised entry price, free-month code, no-obligation free consultation, and dual 4.9-star third-party ratings plus proprietary protocol claims. Both offer compounded GLP-1 medications and both note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Choose Gala if you want a single flat all-inclusive price, free two-day shipping, and the specific $220 promotion documented in Gala’s captured evidence. Choose IVIM Health if you value low starting monthly pricing, a free-month membership code and a no-obligation free consult plus strong third-party ratings and a clinician-guided protocol claim.